179 related articles for article (PubMed ID: 17986279)
1. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
[TBL] [Abstract][Full Text] [Related]
2. Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma.
Liu YY; Stokkel MP; Pereira AM; Corssmit EP; Morreau HA; Romijn JA; Smit JW
Eur J Endocrinol; 2006 Apr; 154(4):525-31. PubMed ID: 16556714
[TBL] [Abstract][Full Text] [Related]
3. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
4. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.
Pitoia F; Tamer EE; Schere DB; Passerieu M; Bruno OD; Niepomniszcze H
Medicina (B Aires); 2006; 66(2):125-30. PubMed ID: 16715760
[TBL] [Abstract][Full Text] [Related]
6. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinoma.
Song HJ; Wu CG; Xue YL; Xu YH; Qiu ZL; Luo QY
Clin Nucl Med; 2012 Jun; 37(6):e129-33. PubMed ID: 22614210
[TBL] [Abstract][Full Text] [Related]
9. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
[TBL] [Abstract][Full Text] [Related]
10. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
Börner AR; Müller-Gärtner HW
Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
12. First treatment activity and outcome of radioiodine therapy in thyroid cancer patients with metastases in lymph nodes: mathematical correlation and clinical implications.
Kozak OV; Muzichenko LV; Trembach AM; Voit NU; Turicina VV
Exp Oncol; 2006 Mar; 28(1):75-9. PubMed ID: 16614713
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine therapy in differentiated thyroid carcinoma.
Salvatori M; Rufini V; Garganese MC; Di Giuda D
Rays; 2000; 25(2):221-38. PubMed ID: 11370540
[TBL] [Abstract][Full Text] [Related]
14. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
15. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
[TBL] [Abstract][Full Text] [Related]
16. [Metastases of a medullary carcinoma of the thyroid (follicular variant). Diagnosis and therapy using radioiodine].
Ruhlmann J; Vogel J; Bockisch A; Biersack HJ
Dtsch Med Wochenschr; 1987 Jul; 112(30):1170-2. PubMed ID: 3608841
[TBL] [Abstract][Full Text] [Related]
17. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma.
Van Tol KM; Hew JM; Jager PL; Vermey A; Dullaart RP; Links TP
Clin Endocrinol (Oxf); 2000 May; 52(5):653-9. PubMed ID: 10792347
[TBL] [Abstract][Full Text] [Related]
18. Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma.
Courbon F; Zerdoud S; Bastie D; Archambaud F; Hoff M; Eche N; Berry I; Caron P
Thyroid; 2006 Oct; 16(10):1025-31. PubMed ID: 17042689
[TBL] [Abstract][Full Text] [Related]
19. [Embolization of skeletal metastases in patients with differentiated thyroid carcinoma].
Smit JW; Links TP; Hew JM; Goslings BM; Vielvoye GJ; Vermey A
Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1406-10. PubMed ID: 10923150
[TBL] [Abstract][Full Text] [Related]
20. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]